Triventures
Triventures is a global venture capital fund founded in 2010 that invests from pre-seed to IPO in healthcare, fintech, and cybersecurity, with a specialized digital health sub-fund (Triventures ARC) partnered with Sheba Medical Center and a tier-1 strategic corporate LP base including Medtronic, J&J, Abbott, and Samsung.
- Company typePrivate
- Founded2010
- HeadquartersHerzliya, Israel
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Triventures does
Triventures is a global venture capital fund founded in 2010 that invests in early-stage companies across healthcare and adjacent sectors including fintech, cybersecurity, and B2B2C. The firm operates two investment vehicles: the core Triventures VC Fund, which invests from pre-seed through Series D and IPO, and Triventures ARC, a seed-stage digital health sub-fund established in partnership with Sheba Medical Center, Israel's largest university-affiliated teaching hospital. The ARC vehicle provides portfolio companies privileged access to Sheba's clinical data assets and an international network of affiliated hospitals across North America and Europe. The fund is co-led by Managing Partners Michal Geva (medtech/digital health operator with exits at Stryker, TransEnterix, Thoratec, and 1-800 Contacts) and Dr. Peter Fitzgerald (Stanford interventional cardiologist and founder of 24 healthcare companies, 18 transitioned to mid/large-cap), with Dr. Martin Leon (Columbia University, founder of CRF and TCT) as Co-Founder and Venture Partner. Triventures generates revenue through conventional VC fund economics — management fees charged to Limited Partners and carried interest on portfolio company exits — and has realized more than 30 exits across its history, including recent acquisitions of CathWorks by Medtronic (2023), V-Wave by Johnson & Johnson (2024), Day Zero Diagnostics by bioMérieux (2025), and Genoox by Qiagen (2025). The firm's Limited Partner base comprises tier-1 strategic corporate investors whose combined market value exceeds $1 trillion, including Medtronic, Abbott, Johnson & Johnson, Boston Scientific, Edwards Lifesciences, Philips, Samsung, NTT, Intermountain Healthcare, and Baptist Health Innovations, with offices in Tel Aviv (Israel HQ) and Portola Valley (Silicon Valley, US).
Triventures firmographics
Firmographics- Name
- Triventures
- Legal name
- Triventures
- Website
- https://triventures.vc
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Triventures is a global venture capital fund founded in 2010 that invests from pre-seed to IPO in healthcare, fintech, and cybersecurity, with a specialized digital health sub-fund (Triventures ARC) partnered with Sheba Medical Center and a tier-1 strategic corporate LP base including Medtronic, J&J, Abbott, and Samsung.
- Ownership category
- akta.pro rank
Triventures industry classification
Industry- Product category
- Healthcare Venture Capital
- NAICS
- Other Investment Pools and Funds (5259), Funds, Trusts, and Other Financial Vehicles (525)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Accelerators & Incubators (Investor-Operated) (FSANAAAM)
Keywords
Where Triventures is headquartered
LocationHeadquarters
- HQ city
- Herzliya
- HQ country
- Israel
- HQ region
- Middle East
Offices2 records
Markets served
Triventures business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Infrastructure, Others
Revenue model
- Fund Management: As a venture capital fund, Triventures generates revenue through management fees charged to Limited Partners (LPs) and carried interest (carry) from successful portfolio company exits.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Triventures product offering
Product offeringCore offering
Triventures is a global venture capital fund that invests capital and provides strategic guidance into early-stage companies in healthcare, digital health, fintech, cybersecurity, and adjacent sectors, typically from pre-seed through Series D and IPO. Its primary offering is fund management for Limited Partners, complemented by a specialized seed-stage digital health sub-fund (Triventures ARC) operated in partnership with Sheba Medical Center that gives portfolio companies direct access to clinical data and hospital networks.
Product overview
Triventures operates as a unified venture capital fund with a specialized healthcare focus. The fund comprises two primary investment vehicles: the core Triventures VC Fund that makes early-stage investments across healthcare, fintech, cybersecurity, and e-commerce, and the Triventures ARC sub-fund which focuses specifically on digital health and smart medical devices in partnership with Sheba Medical Center. The ARC program provides portfolio companies with access to Sheba's vast health data assets and international hospital network.
Differentiator
Problem solved
Functional benefit
Brands
- Triventures ARC: A seed-stage digital healthcare and smart medical devices fund operated in partnership with Sheba Medical Center's ARC Innovation Center.
Products and services
- Triventures VC Fund A global venture capital fund that invests in early-stage companies with validated business models across healthcare, fintech, cybersecurity, and e-commerce, with strategic presence in the US, Israel, and Canada. Investments span pre-seed through Series D and IPO stages, targeting bio-convergence and data-driven technologies. Investors are institutional Limited Partners and strategic corporate partners; capital is deployed via direct equity rounds into portfolio companies.
- Triventures ARC Fund A seed-stage digital healthcare and smart medical devices fund operated in partnership with Sheba Medical Center's ARC Innovation Center. Portfolio companies gain direct access to Sheba's clinical data assets and Sheba's network of affiliated hospitals in North America and Europe, plus the broader ARC innovation ecosystem. Triventures ARC is the venture capital arm of the ARC Innovation Center, a health-tech hub inside Sheba Medical Center.
Companies that use Triventures
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
Triventures technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Triventures partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Sheba Medical CentercoreTriventures partnered with Sheba Medical Center, Israel's largest university-affiliated teaching hospital (recognized by Newsweek as one of the world's top ten hospitals), to establish Triventures ARC. Portfolio companies benefit from Sheba's data assets and network of affiliated hospitals in North America and Europe.
Scale indicators4 records
Recent moves7 records
Expansion highlights5 records
Triventures competitors and assessment
Company assessmentDirect peers
- Andreessen Horowitz (a16z Bio): a16z's Bio/Health fund is a leading digital health and bio-convergence investor with multi-hundred-million-dollar fund vintages, directly comparable to Triventures' thesis and stage focus.
- Khosla Ventures: Khosla has been a long-standing digital health and bio-tech seed-to-growth investor, overlapping directly with Triventures' early-stage healthcare focus.
- Bessemer Venture Partners: BVP's healthcare practice and growth-stage investing model parallels Triventures' strategy of backing health-tech companies from early-stage through exit, including IPO-stage opportunities.
- New Enterprise Associates (NEA): NEA is a multi-stage healthcare-focused investor with deep life sciences and digital health portfolios, directly competing for the same founder relationships and exit partners.
- General Catalyst: General Catalyst's Health Assurance and bio bets overlap materially with Triventures' digital health thesis, including transformation-of-care investments and tier-1 LP relationships.
- GV (Google Ventures): GV invests across life sciences and digital health at seed-to-growth stages, with a similarly global footprint and strategic LP-style engagement with portfolio founders.
- Section32: Section32 is a digital health-dedicated venture fund investing at seed and Series A — a near-direct competitor to Triventures ARC in the digital health seed market.
- Define Ventures: Define Ventures is an early-stage digital health-only fund with tier-1 strategic LP backing, directly comparable to Triventures' positioning around healthcare transformation.
- Lux Capital: Lux invests at the intersection of science, technology, and health, with comparable bio-convergence thesis and early-stage healthcare bets overlapping Triventures' portfolio.
- Optum Ventures: Optum Ventures is a corporate-led digital health investor backed by UnitedHealth Group, directly comparable as a strategic-corporate-LP-driven digital health investor.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Triventures social profiles
Digital presenceTriventures financial estimates
Financial estimateRevenue estimate
Valuation estimate
Triventures leadership team
Management profileNumber of profiles
Profiles8 records
Triventures funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Triventures M&A and investment
M&A and investmentM&A
Investments59 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Triventures
What does Triventures do?
Triventures is a global venture capital fund that invests capital and provides strategic guidance into early-stage companies in healthcare, digital health, fintech, cybersecurity, and adjacent sectors, typically from pre-seed through Series D and IPO. Its primary offering is fund management for Limited Partners, complemented by a specialized seed-stage digital health sub-fund (Triventures ARC) operated in partnership with Sheba Medical Center that gives portfolio companies direct access to clinical data and hospital networks.
Is Triventures a public or private company?
Triventures is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Triventures founded?
Triventures was founded in 2010. It employs 1 to 10 people.
Where is Triventures based?
Triventures is headquartered in Herzliya, Israel, in the Middle East region.
How does Triventures make money?
One revenue line is on record: fund Management.
Who are Triventures's main competitors?
Direct peers on record are Andreessen Horowitz (a16z Bio), Khosla Ventures, Bessemer Venture Partners, New Enterprise Associates (NEA), General Catalyst, GV (Google Ventures), Section32, Define Ventures, Lux Capital and Optum Ventures.
Does Triventures have an API?
No public API is recorded for Triventures.
What industry is Triventures in?
Triventures's product category is Healthcare Venture Capital. Its primary akta.pro industry code is FSANAAAM, Accelerators & Incubators (Investor-Operated). Its NAICS code is 5259 and its SIC code is 6282.